| __timestamp | Halozyme Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 75334000 | 9757000 |
| Thursday, January 1, 2015 | 135057000 | 1253000 |
| Friday, January 1, 2016 | 146691000 | 5421000 |
| Sunday, January 1, 2017 | 316613000 | 154584000 |
| Monday, January 1, 2018 | 151862000 | 301034000 |
| Tuesday, January 1, 2019 | 195992000 | 380833000 |
| Wednesday, January 1, 2020 | 267594000 | 540099000 |
| Friday, January 1, 2021 | 443310000 | 701887000 |
| Saturday, January 1, 2022 | 660116000 | 933013000 |
| Sunday, January 1, 2023 | 829253000 | 1243336000 |
| Monday, January 1, 2024 | 1015324000 |
Data in motion
In the competitive landscape of biotechnology, Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc. have demonstrated remarkable revenue trajectories over the past decade. From 2014 to 2023, Sarepta's revenue surged by an astounding 12,600%, reflecting its strategic advancements in genetic medicine. Meanwhile, Halozyme's revenue grew by over 1,000%, showcasing its prowess in drug delivery technologies.
By 2023, Sarepta's revenue reached approximately 1.24 billion, outpacing Halozyme's 829 million by nearly 50%. This growth underscores Sarepta's successful market penetration and innovation in treating rare diseases. Halozyme, however, has consistently expanded its revenue base, doubling its figures from 2020 to 2023.
These trends highlight the dynamic nature of the biotech sector, where innovation and strategic focus can lead to exponential growth, setting the stage for future breakthroughs.
AbbVie Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
AstraZeneca PLC or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?
Revenue Insights: Pfizer Inc. and Sarepta Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Revenue Insights: Genmab A/S and Sarepta Therapeutics, Inc. Performance Compared
Revenue Showdown: Viatris Inc. vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Sarepta Therapeutics, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: Sarepta Therapeutics, Inc. vs Perrigo Company plc
Annual Revenue Comparison: Sarepta Therapeutics, Inc. vs Vericel Corporation
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.
Revenue Insights: Ascendis Pharma A/S and Halozyme Therapeutics, Inc. Performance Compared